Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma

Modern Pathology

Volumn 27, Issue 1, 2014, Pages 62-72

  Joseph, Nancy M ^a   Ferrell, Linda D ^a   Jain, Dhanpat ^b   Torbenson, Michael S ^c   Wu, Tsung Teh ^d   Yeh, Matthew M ^e   Kakar, Sanjay ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

c reactive protein; focal nodular hyperplasia; glutamine synthetase; hepatocellular adenoma; serum amyloid associated protein

Indexed keywords

AMYLOID ASSOCIATED PROTEIN; BETA CATENIN; C REACTIVE PROTEIN; GLUTAMATE AMMONIA LIGASE; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ADENOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHILD; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY HEPATOCELLULAR ADENOMA; LIVER BIOPSY; LIVER HEMORRHAGE; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NODULAR HYPERPLASIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SCHOOL CHILD; STAINING; STEATOSIS; TELANGIECTASIA; YOUNG ADULT;

ADENOMA, LIVER CELL; ADOLESCENT; ADULT; AGED; BIOPSY; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FEMALE; FOCAL NODULAR HYPERPLASIA; GLUTAMATE-AMMONIA LIGASE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SERUM AMYLOID A PROTEIN; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84891745667     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.114     Document Type: Article

References (31)

1. Bioulac-Sage P, Laumonier H, Cubel G, et al. Over-expression of glutamine synthase in focal nodular hyperplasia (part 1): early stages in the formation support the hypothesis of a focal hyper-arterialisation with venous (portal and hepatic) and biliary damage. Comp Hepatol 2008;7:2.
2. Nguyen BN, Flejou JF, Terris B, et al. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999;23:1441-1454.
3. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985;5:1194-1200. (Pubitemid 16222291)
4. Lepreux S, Laurent C, Le Bail B, et al. Multiple telangiectatic focal nodular hyperplasia: vascular abnormalities. Virchows Arch 2003;442:226-230. (Pubitemid 36399215)
5. Wanless IR, Albrecht S, Bilbao J, et al. Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol 1989;2: 456-462.
6. Bioulac-Sage P, Balabaud C, Bedossa P, et al. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 2007;46:521-527. (Pubitemid 46201719)
7. Bioulac-Sage P, Rebouissou S, Sa Cunha A, et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005;128:1211-1218. (Pubitemid 40712173)
8. Paradis V, Benzekri A, Dargere D, et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 2004;126:1323-1329. (Pubitemid 38559002)
9. Paradis V, Laurent A, Flejou JF, et al. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology 1997;26:891-895. (Pubitemid 27413654)
10. Paradis V, Bieche I, Dargere D, et al. A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. Gastroenterology 2003; 124:651-659. (Pubitemid 36268484)
11. Bioulac-Sage P, Balabaud C, Wanless IR. Focal nodular hyperplasia and hepatocellular adenoma, In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds). WHO Classification of Tumours of the Digestive System, 4th edn, vol. 3, Chapter 10. IARC: Lyon, France; 2010, pp 198-204.
12. Burke ZD, Tosh D. The Wnt/beta-catenin pathway: master regulator of liver zonation Bioessays 2006;28:1072-1077. (Pubitemid 44714116)
13. Walther Z, Jain D. Molecular pathology of hepatic neoplasms: classification and clinical significance. Patholog Res Int 2011; 2011;403929.
14. Bioulac-Sage P, Cubel G, Taouji S, et al. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. Am J Surg Pathol 2012;36:1691-1699.
15. Bioulac-Sage P, Laumonier H, Rullier A, et al. Overexpression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 2009;29:459-465.
16. Rebouissou S, Couchy G, Libbrecht L, et al. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 2008;49:61-71.
17. Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007;46:740-748. (Pubitemid 47436120)
18. Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Dig Surg 2010;27:39-45.
19. Pilati C, Amessou M, Bihl MP, et al. Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med 2011;208:1359-1366.
20. Rebouissou S, Amessou M, Couchy G, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009; 457:200-204.
21. Laumonier H, Frulio N, Laurent C, et al. Focal nodular hyperplasia with major sinusoidal dilatation: a misleading entity. BMJ Case Rep 2010.
22. Suriawinata AA, Lim KH, Fiel MI, et al. Useful pathologic features to distinguish telangiectatic/inflammatory hepatocellular adenoma from other benign hepatocellular tumors. Mod Pathol 2009;22:323A.
23. Evason KJ, Grenert JP, Ferrell LD, et al. Atypical hepatocellular adenoma-like neoplasms with betacatenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas. Hum Pathol 2013;44:750-758.
24. Mounajjed T, Wu TT. Telangiectatic variant of hepatic adenoma: clinicopathologic features and correlation between liver needle biopsy and resection. Am J Surg Pathol 2011;35:1356-1363.
25. Gru A, Pai RK, Brunt EM. Clinicopathologic and molecular characterization of hepatocellular adenomas and focal nodular hyperplasia. Mod Pathol 2010;23:356A.
26. Gebhardt R, Baldysiak-Figiel A, Krugel V, et al. Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver. Prog Histochem Cytochem 2007;41:201-266. (Pubitemid 46412421)
27. Akutsu N, Wakasugi H, Ohzeki R, et al. [Hyperplastic hepatic nodules in a case of idiopathic portal hypertension: changes in imaging findings during a 6-year follow-up]. Nihon Shokakibyo Gakkai Zasshi 2010;107:102-111.
28. Cazals-Hatem D, Vilgrain V, Genin P, et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology 2003;37:510-519. (Pubitemid 36258771)
29. Cho SWI, Paradis V, et al. FNH-like lesions and glutamine synthetase expression in the liver in hereditary hemorrhagic telangiectasia. Mod Pathol 2011;24(Suppl.1):358A (abstract).
30. Libbrecht L, Cassiman D, Verslype C, et al. Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol 2006;101:2341-2346. (Pubitemid 44477563)
31. Lepreux S, Laurent C, Balabaud C, et al. FNH-like nodules: possible precursor lesions in patients with focal nodular hyperplasia (FNH). Comp Hepatol 2003;2:7.